BioCentury
ARTICLE | Financial News

Orig3n completes venture financing

February 9, 2015 8:00 AM UTC

Orig3n Inc., Boston, Mass. Business: Gene/Cell therapy, Neurology Date completed: 2015-02-05 Type: Venture financing Raised: $3.1 million Investors: Hatteras Venture Partners; Harris & Harris Group; K...